Status:
COMPLETED
Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atopic dermatitis (AD) is a very common disorder that is characterized by pruritic inflammatory skin lesions, with patients usually having an individual or family history of atopic diseases in their b...
Detailed Description
Atopic dermatitis (AD) is a very common disorder that is characterized by pruritic inflammatory skin lesions, with patients usually having an individual or family history of atopic diseases in their b...
Eligibility Criteria
Inclusion
- Patients with chronic AD (Hanifin and Rajka, 1980); moderate to severe disease with SCORAD-index \> 30 (maximum = 102).
- Age \> 18 years
- No topical steroids (except 1% hydrocortisone) or topical/systemic antibiotics or antihistamines within the last 2 weeks, no systemic glucocorticosteroids or other immunosuppressive agents within the last 8 weeks, no phototherapy within the last 12 weeks before inclusion
Exclusion
- Pregnancy or lactation
- Skin cancer or dysplastic naevi, photosensitive skin diseases, autoimmune diseases or relevant cardiovascular diseases
- Photo-skin type I according to Fitzpatrick
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00419406
Start Date
March 1 2005
End Date
December 1 2007
Last Update
January 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Ruhr University Bochum
Bochum, North Rhine-Westphalia, Germany, 44791